The systemic delivery of aspirin-trigged analog, AT-RvD1, or 17(R)-RvD1 is also described to reduced CFA-induced arthritis hyperalgesia and cytokines expression (TNF-α and IL-1β; Lima-Garcia et al., 2011). This evidence concerns the gene IL1B and arthritic joint disease.